Abstract
Background:
Chronic gastrointestinal disorders such as gastroesophageal reflux disease (GERD), pangastritis, and post-pancreatitis digestive dysfunction are commonly managed through acid suppression and symptom-oriented interventions. While effective for short-term control, these strategies often inadequately address underlying metabolic, inflammatory, and psycho-behavioral drivers, resulting in symptom recurrence, impaired tissue recovery, and long-term disease progression.
Objectives:
To evaluate the role of an integrative gastroenterology approach combining conventional diagnostics with Ayurveda-based interventions in restoring digestive function, reducing symptom recurrence, and improving overall metabolic and inflammatory status in chronic gastrointestinal conditions.
Methodology:
Two clinical cases were analysed. Case 1 involved a 40-year-old male with recurrent GERD, pangastritis, and Grade I esophagitis. Case 2 involved a 59-year-old female with severe digestive impairment following acute pancreatitis. Both patients underwent standard diagnostic evaluations including endoscopy and biochemical investigations. An integrative treatment protocol was implemented, incorporating Ayurveda-guided personalised dietary modulation, lifestyle restructuring, stress management, and targeted therapies aimed at restoration of digestive capacity (Agni), tissue nourishment (Dhatu), and systemic resilience (Ojas). Patients were followed longitudinally to assess clinical, functional, and symptomatic outcomes.
Results:
Both cases demonstrated significant and sustained symptomatic improvement, enhanced digestive tolerance, and reduced dependence on long-term acid suppression or supportive medications. Improvements were observed in reflux and dyspeptic symptoms as well as in energy levels, appetite regulation, and stress tolerance. No disease progression or recurrence was noted during follow-up.
Conclusion:
These cases highlight the limitations of symptom-centric gastrointestinal management and demonstrate the potential of integrative gastroenterology grounded in Ayurveda principles. A model integrating evidence-based diagnostics and pharmacotherapy with personalised, root-cause-oriented interventions and longitudinal monitoring may support sustainable digestive recovery and whole-person health.
Introduction
Chronic gastrointestinal disorders, including gastroesophageal reflux disease (GERD) and gastritis, affect millions globally and are typically managed with proton pump inhibitors (PPIs), endoscopic evaluation, and basic lifestyle recommendations.[1,2] While effective for immediate symptom relief, these strategies often overlook underlying metabolic dysfunction, chronic inflammation, and psycho-behavioural stressors, resulting in symptom relapse and increased risk of complications such as Barrett’s oesophagus or gastrointestinal malignancies.[3] Ayurveda, an ancient medical system, conceptualises these disorders as manifestations of systemic imbalances, particularly dysregulation of digestive fire (‘Agni’), driven by diet, lifestyle, and stress.[4] This holistic approach emphasises personalised interventions to restore systemic balance and prevent disease progression.
Severe gastrointestinal conditions, such as post-acute necrotising pancreatitis, further underscore the limitations of conventional care. While surgical and pharmacological interventions address acute anatomical and biochemical derangements, patients often experience persistent digestive fragility, malnutrition, and psychological sequelae.[5]
Integrative approaches combining conventional diagnostics with Ayurveda strategies—focusing on diet, lifestyle, and psycho-emotional health—offer a pathway to bridge reactive symptom management with proactive prevention. This short article presents two clinical cases to illustrate this paradigm shift and proposes a framework for integrative gastroenterology to optimise long-term outcomes.
Case Archetypes
Case 1
A 40-year-old South Indian male presented with recurrent heartburn, retrosternal burning, upper abdominal discomfort, migraines, and a mixed anxiety-depression profile. His history included frequent consumption of spicy, oil-rich meals, prolonged alcohol use, and significant psycho-behavioural stressors, including childhood trauma and financial strain. Initial conventional management involved a brief consultation with a gastroenterologist, prescribing antacids and PPIs. Endoscopy revealed pangastritis and Grade I esophagitis, but no H. pylori testing or lifestyle counselling was documented. Symptoms improved temporarily but recurred post-therapy cessation. An Ayurveda consultation assessed diet, meal timing, sleep quality, daily routine, and psycho-behavioural history. Management focused on a tailored diet, structured routine, stress mitigation, and therapies to restore digestive efficiency and metabolic homeostasis, achieving sustained symptom control and improved mental well-being.
Case 2
A 59-year-old female, weighing 30 kg, presented in March 2025, with a history of acute necrotising pancreatitis and common bile duct obstruction diagnosed in 2024. Following endoscopic retrograde cholangiopancreatography (ERCP) and six surgical interventions, she experienced persistent digestive sensitivity, recurrent gastrointestinal infections, and chronic vomiting every 24–48 hours, leading to severe malnutrition and psychological aversion to food. Ayurveda management at our hospital prioritised restoration of ‘Agni’ through a personalised, gentle dietary regimen, discontinuing protein-rich supplements that her digestion could not tolerate. By 1 April 2025, vomiting ceased, and by 5 April, her weight increased to 33 kg. Her psychological engagement with food and life improved, reflecting restoration of physical, emotional, and sensory vitality (‘Ojas’). This case demonstrates the efficacy of integrative care in addressing complex gastrointestinal and psycho-emotional dysfunction.[6]
Pathophysiology and Integrative Rationale
Chronic gastrointestinal disorders often reflect a lifetime of inflammatory and metabolic insults. Dietary irritants, alcohol exposure, and psycho-behavioural stress contribute to persistent low-grade inflammation, disrupting gastrointestinal mucosa and promoting oxidative damage.[7] Such insults impair tissue repair, increase insulin resistance, and elevate risks of metabolic syndrome and oncogenic transformations.[8] Prolonged use of PPIs (>3 months) is associated with risks, including hypergastrinemia, altered gastric microbiota, and increased gastric and oesophageal cancer risk.[9,10] Ayurveda interventions, including personalised diet (‘Ahara’), lifestyle routines (‘Dinacharya’), and stress-modulating practices like yoga and meditation, complement conventional approaches by addressing systemic inflammation and restoring digestive function.[11–12]
Proposed Integrative Framework
An integrative gastroenterology model combines conventional diagnostics—such as endoscopy, H. pylori testing, stool analysis, pH impedance studies, and short-term PPI therapy for acute needs—with Ayurveda principles of digestive restoration to provide accurate pathology characterisation while addressing systemic imbalances. This strengthened framework shifts care from symptom suppression to long-term risk modification by targeting the metabolic, inflammatory, and psycho-emotional drivers of chronic gastrointestinal disease.
Foundational Diagnostics and Risk Stratification (Conventional + Ayurveda Assessment)
Comprehensive baseline assessment: endoscopic findings, mucosal status, H. pylori evaluation, abdominal ultrasound, and pertinent biochemical markers.
Ayurveda assessment covering Nidra, Agni, Ama, Mala, Mutra, Manas and Ojas.
Combined stratification helps identify patients at risk for progression to mucosal injury, dysplasia, metabolic disturbances, or post-pancreatitis digestive compromise.
Dual-track Therapeutic Pathways (Acute Stabilisation + Longitudinal Restoration)
Acute phase: short-course PPIs, mucosal protectants, and antibiotics where indicated, along with Ayurveda measures to stabilise Agni such as light, digestible meals and structured daily routines.
Restorative phase: personalised diet (Ahara), circadian lifestyle routines (Dinacharya), mind-gut regulation practices (yoga, breathwork, meditation), and Ayurveda therapies planned to enhance mucosal healing, reduce inflammation, regulate motility, and rebuild Ojas.
Longitudinal Surveillance and Risk Mitigation
Periodic monitoring of blood biomarkers, inflammatory indicators, metabolic parameters, and nutritional status.
Imaging surveillance using abdominal ultrasound or other modalities based on phenotype.
Dietary protocols designed to minimise dysbiosis, lower chronic inflammation, and reduce the long-term risk of precancerous or metabolic progression.
This systematic surveillance structure functions as a safety net, preventing relapse and enabling early identification of risk escalation.
Multidisciplinary Integrative Care Team (MICT)
Gastroenterologists provide diagnostic clarity and guide acute interventions.
Ayurveda clinicians address digestive strength, metabolic correction, and long-term restoration.
Ayurveda Dieticians + Conventional nutrition specialists operationalise nutrition plans compatible with both systems.
Psychologists/Yoga experts address trauma, anxiety, and stress patterns driving symptom cycles.
This team-based approach ensures safe, continuous, and patient-centred care as each one is in active communication.
Digital Integration, Outcomes Tracking, and EMR Alignment
Electronic medical records capture symptom scoring, digestive function trends, sleep and stress metrics, and nutritional & metabolic indices.
Dynamic tracking allows step-up/step-down care and supports personalised plans.
Consolidated documentation improves continuity, transparency, and clinical governance across systems.
Implementation Science: Structured Pathways and Quality Assurance
Establishment of standardised integrative pathways for GERD, gastritis, dyspepsia, IBS, and post-pancreatitis recovery.
Training clinicians across disciplines to recognise red flags, understand shared mechanisms, and coordinate care.
Regular quality audits, case reviews, and Plan-Do-Study-Act cycles to refine clinical processes based on outcome trends.
Research and Evidence Expansion
Systematic evaluation of Ayurveda diet, lifestyle, and therapeutic protocols in mucosal healing, symptom recurrence prevention, inflammatory reduction, and quality-of-life improvement.
Mixed-method studies to assess functional outcomes, patient-reported benefits, and reductions in long-term pharmacologic exposure.
Collaborative research platforms to generate high-quality evidence supporting integrative gastroenterology models in chronic GI disorders.
Conclusion
Chronic gastrointestinal disorders highlight the limitations of symptom-focused care. Integrative gastroenterology, blending conventional diagnostics and pharmacotherapy with Ayurveda principles of digestive restoration, lifestyle modification, addressing inner microenvironment and psycho-emotional support, offers a proactive approach to mitigate metabolic, inflammatory, and oncogenic risks. The presented cases demonstrate that addressing root causes through personalised interventions achieves sustained functional recovery and whole-person health.
Footnotes
Acknowledgements
I express my sincere gratitude to all the patients and their families for their trust, cooperation, and willingness to allow their clinical experiences to contribute to advancing medical understanding.
My heartfelt thanks to the Apollo AyurVAID clinical team for their unwavering commitment to patient care and for supporting the integrative approach that made this work possible. I remain deeply grateful to Mr Rajiv Vasudevan, Founder and CEO, for his mentorship and for providing me with the platform and institutional environment to pursue rigorous, evidence-informed Ayurveda-led integrative care.
I extend my special thanks to Professor Dr Dhavendra, Dr Arun Agarwal, and Dr Anjali Arya for inviting me to contribute to this very special issue of Integrative Medicine. Their encouragement and vision for integrative health continue to inspire meaningful scientific dialogue and collaborative progress.
Declaration of conflicting interests
The author declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Funding
The author received no financial support for the research, authorship and/or publication of this article.
Institutional ethical committee approval number
Not applicable.
Credit author statement
Zankhana Buch contributed to everything for this article.
Data availability statement
Nil.
Use of artificial intelligence
No Artificial Intelligence was used.
